YGION Biomedical, an Austrian biotechnology firm, is dedicated to transforming personalized cancer immunotherapy into reality. By harnessing advanced technologies, it aims to develop tailored treatments that empower patients in their battle against cancer, offering hope and improved outcomes through innovative therapeutic solutions.
National Ranking115th
in Philippines Regional Ranking1921st
in South East Asia Global Ranking52464th
worldwide Rankings by
